Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,491	1,406	739.46	455.35	519.07	560.96
Short-Term Investments	869.1	1,025	156.53	30.87	-	-
Cash & Short-Term Investments	2,360	2,431	895.99	486.22	519.07	560.96
Cash Growth	-3.55%	171.32%	84.28%	-6.33%	-7.47%	227.56%
Receivables	-	-	-	0.84	-	-
Prepaid Expenses	21.37	2	3.56	9.96	9.62	7.7
Other Current Assets	13.16	8.58	3.47	0.55	0.01	22.76
Total Current Assets	2,394	2,442	903.02	497.57	528.69	591.42
Property, Plant & Equipment	14.38	13.58	12.77	9.78	9.1	7.75
Long-Term Investments	59.85	21.46	-	-	-	-
Long-Term Deferred Tax Assets	55.93	48.27	54.97	13	-	-
Other Long-Term Assets	0.27	31.2	2.45	2.25	2.11	4.8
Total Assets	2,525	2,556	973.21	522.6	539.91	603.98
Accrued Expenses	-	6.69	20.48	2.02	2.17	2
Current Portion of Leases	1.63	0.3	1.27	1.29	0.68	0.91
Current Income Taxes Payable	46.97	45.67	49.45	-	-	-
Current Unearned Revenue	-	1.25	1.25	-	-	-
Other Current Liabilities	25.82	1.16	2.32	2.06	1.61	1.22
Total Current Liabilities	74.42	55.08	74.77	5.37	4.46	4.13
Long-Term Leases	0.83	0.31	0.14	1.41	0.27	0.61
Long-Term Deferred Tax Liabilities	-	7.39	-	0.33	-	-
Other Long-Term Liabilities	1.62	1.49	1.18	0.99	0.81	0.63
Total Liabilities	76.86	64.26	76.09	8.1	5.54	5.37
Common Stock	668	668	570	570	570	570
Additional Paid-In Capital	1,579	1,579	-	-	424.04	424.04
Retained Earnings	201.24	245.09	327.12	-55.5	-459.67	-395.44
Shareholders' Equity	2,448	2,492	897.12	514.5	534.37	598.6
Total Liabilities & Equity	2,525	2,556	973.21	522.6	539.91	603.98
Total Debt	2.46	0.6	1.41	2.69	0.95	1.52
Net Cash (Debt)	2,357	2,430	894.58	483.53	518.12	559.44
Net Cash Growth	-3.62%	171.69%	85.01%	-6.68%	-7.39%	231.33%
Net Cash Per Share	35.39	36.70	15.68	8.48	9.09	11.21
Filing Date Shares Outstanding	65.95	66.8	57	57	57	57
Total Common Shares Outstanding	65.95	66.8	57	57	57	57
Working Capital	2,320	2,387	828.25	492.2	524.24	587.3
Book Value Per Share	37.12	37.30	15.74	9.03	9.37	10.50
Tangible Book Value	2,448	2,492	897.12	514.5	534.37	598.6
Tangible Book Value Per Share	37.12	37.30	15.74	9.03	9.37	10.50
Machinery	-	27.15	22.99	16.65	16.42	12.07
Leasehold Improvements	-	0.98	0.98	0.98	1.05	1.05

Updated Mar 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.